Ụdị nke Tylvalosin Tartrate

Nkọwa dị mkpirikpi:

CASnọmba: 63428-13-7

Usoro ihe omimi:C53H87NO19

Uru:Enweghị oge nkwụsị (ụbọchị 0);Oke nchekwa sara mbara

 Ọdịnaya: ≥ 98%

Nkwakọ ngwaahịa:25kg / kaadiboodu drum

Nkwadebe:

Tylvalosin premix

Tylvalosin ngwọta

Tylvalosin tartrate premix 20%, 50%


Ọnụ ego FOB US $ 0.5 - 9,999 / akụkụ
Ọnụ ọgụgụ nke Min 1 Iberibe/Iberibe
Ikike inye 10000 Iberibe/Iberibe kwa ọnwa
Oge ịkwụ ụgwọ T/T, D/P, D/A, L/C
ezi anụ ọkụkọ turkey

Nkọwa ngwaahịa

Nkọwapụta Ụlọ ọrụ

Mkpado ngwaahịa

Pharmacology na Toxicology

Tylvalosinnwere ọrụ antibacterial megide nje bacteria dị iche iche nke gram-positive, dị ka Staphylococcus, Micrococcus, Microbacteria, Bacillus, Corynebacterium, Balloon bacteria, Campylobacter, Enterococcus, Streptococcus, Arthrobacter, wdg;Mycoplasma nwekwara ezigbo ọrụ antibacterial ma na-arụ ọrụ nke ọma na nnukwu mkpokọta;mana ọ nweghị mmetụta na ọtụtụ nje bacteria gram-adịghị mma.

Ụdị nke Tylvalosin Tartrate

Pharmacological omume

1.The kasị dị irè anụmanụ ọgwụ nje na Mycoplasma suis na ileitis ịnọgide na-enwe nkịtị ọrụ nke dịghịzi usoro nke iku ume mucosa iji gbochie pathogen mgbapụ.Ọgwụgwọ na Mycoplasma suis na-abanye ngwa ngwa n'ime sel epithelial intestinal ma na-arụ ọrụ na ribosomes nke intracellular Lawsonia iji gbuo nje bacteria.

2.Mmelite n'ozuzu mgbochi site n'ịkwalite macrophage metabolism na ịba ụba nke macrophages na lysosomal proteins na macrophages.

3.Mgbochi mmeghari PRRS.

Ngosipụta

Ezi: ọgwụgwọ na methaphylaxis nke ezì enzootic oyi baa;Ọgwụgwọ nke porcine proliferative enteropathy (ileitis);Ọgwụgwọ na methaphylaxis nke ọnyụnyụ ezì.

Chickens: Ọgwụgwọ na methaphylaxis nke ọrịa iku ume metụtara Mycoplasma gallisepticum na ọkụkọ.,

Turkeys: Ọgwụgwọ ọrịa iku ume jikọtara ya na ụdị tylvalosin nwere mmetụta nke Ornithobacterium rhinotracheale na turkey.

Ngwa ụlọ ọgwụ na mmeghachi omume ọjọọ

Enwere ike iji nkwadebe Tylvalosin (dị ka premixes, powders soluble na granules) na ụlọ ọgwụ iji gbochie ma gwọọ ụkwara ume ọkụ nke Mycoplasma suis kpatara, ọnyụnyụ ezì nke B. hyodysenteriae kpatara, na Lawsonia intracellularis Porcine proliferative enteritis na Mycoplasma gallisepticum ọrịa Mycoplasma gallisepticum kpatara site na Mycoplasma.Ọtụtụ ule ubi ekwenyela na Tyvanectin nwere mmetụta dị ukwuu na ọgwụgwọ ụkwara ume ọkụ ezì, ọnyụnyụ ezì na porcine proliferative enteritis, na nchekwa dị elu na enweghị mmeghachi omume ọjọọ.Ndị na-eme nchọpụta na-enye ezi pigs ule na ugboro 5, ugboro 10 ma ọ bụ ọbụna ugboro 20 nke akwadoro.Nnyocha ahụ chọpụtara na tyvans enweghị mmetụta ọ bụla na ịdị arọ anụ ezi, nri nri, hematology, biochemistry ọbara, histopathology, wdg, nke zuru oke.Ọ na-egosi na tyvans enweghị mmeghachi omume ọjọọ mgbe ejiri ya na ezì, ọ nwekwara nchekwa dị elu.

Uru

Enweghị oge nkwụsị (ụbọchị 0);

Oke nchekwa sara mbara

Nkwadebe

Tylvalosin premix;Tylvalosin ngwọta;Tylvalosin tartrate premix 20%, 50%

Ọdịnaya

≥ 98%

Nkwakọ ngwaahịa

25kg / kaadiboodu drum


  • Nke gara aga:
  • Osote:

  • https://www.veyongpharma.com/about-us/

    Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.

    Veyong (2)

    Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.

    HEBEI VEYONG
    Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.

    Ọnụ ego nke VEYONG PHARMA

    Ngwaahịa ndị emetụtara